Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guihong Wan

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Cancers|December 10, 2021
An Observational Study on the Molecular Profiling of Primary Melanomas Reveals a Progression Dependence on Mitochondrial ActivationJeovanis Gil, Melinda Rezeli, Elmar G Lutz, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
SpatialCells: Automated Profiling of Tumor Microenvironments with Spatially Resolved Multiplexed Single-Cell DataGuihong Wan, Zoltan Maliga, Boshen Yan, et al.
Journal of the American Academy of Dermatology|March 21, 2023
Increased risk of cutaneous immune-related adverse events in patients treated with talimogene laherparepvec and immune checkpoint inhibitors: A multi-hospital cohort studyBonnie W Leung, Guihong Wan, Nga Nguyen, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Spatial determinants of tumor cell dedifferentiation and plasticity in primary cutaneous melanomaTuulia Vallius, Yingxiao Shi, Edward Novikov, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2025
Effect of systemic glucocorticoid immunosuppression timing, dose, and duration on overall survival among immune checkpoint inhibitor recipients: a retrospective multicohort studyGuihong Wan, Nga Nguyen, Charles Lu, et al.
JAMA Network Open|May 22, 2026
Systemic Glucocorticoid Immunosuppression and Survival Among Immune Checkpoint Inhibitor RecipientsGuihong Wan, Nga Nguyen, Charles Lu, et al.
JAAD International|November 25, 2022
The impact of stage-related features in melanoma recurrence prediction: A machine learning approachGuihong Wan, Bonnie Leung, Nga Nguyen, et al.
The Lancet. Oncology|July 18, 2024
Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort studyGuihong Wan, Wenxin Chen, Sara Khattab, et al.
The British Journal of Dermatology|February 17, 2024
Cancer type and histology influence cutaneous immunotherapy toxicities: a multi-institutional cohort studyGuihong Wan, Sara Khattab, Bonnie W Leung, et al.
Journal of the American Academy of Dermatology|October 14, 2023
Pre-existing inflammatory disease predicts cutaneous immunotherapy toxicity development: A multi-institutional cohort studyGuihong Wan, Nga Nguyen, Bonnie W Leung, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Cancers|December 10, 2021
An Observational Study on the Molecular Profiling of Primary Melanomas Reveals a Progression Dependence on Mitochondrial ActivationJeovanis Gil, Melinda Rezeli, Elmar G Lutz, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
SpatialCells: Automated Profiling of Tumor Microenvironments with Spatially Resolved Multiplexed Single-Cell DataGuihong Wan, Zoltan Maliga, Boshen Yan, et al.
Journal of the American Academy of Dermatology|March 21, 2023
Increased risk of cutaneous immune-related adverse events in patients treated with talimogene laherparepvec and immune checkpoint inhibitors: A multi-hospital cohort studyBonnie W Leung, Guihong Wan, Nga Nguyen, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Spatial determinants of tumor cell dedifferentiation and plasticity in primary cutaneous melanomaTuulia Vallius, Yingxiao Shi, Edward Novikov, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2025
Effect of systemic glucocorticoid immunosuppression timing, dose, and duration on overall survival among immune checkpoint inhibitor recipients: a retrospective multicohort studyGuihong Wan, Nga Nguyen, Charles Lu, et al.
JAMA Network Open|May 22, 2026
Systemic Glucocorticoid Immunosuppression and Survival Among Immune Checkpoint Inhibitor RecipientsGuihong Wan, Nga Nguyen, Charles Lu, et al.
JAAD International|November 25, 2022
The impact of stage-related features in melanoma recurrence prediction: A machine learning approachGuihong Wan, Bonnie Leung, Nga Nguyen, et al.
The Lancet. Oncology|July 18, 2024
Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort studyGuihong Wan, Wenxin Chen, Sara Khattab, et al.
The British Journal of Dermatology|February 17, 2024
Cancer type and histology influence cutaneous immunotherapy toxicities: a multi-institutional cohort studyGuihong Wan, Sara Khattab, Bonnie W Leung, et al.
Journal of the American Academy of Dermatology|October 14, 2023
Pre-existing inflammatory disease predicts cutaneous immunotherapy toxicity development: A multi-institutional cohort studyGuihong Wan, Nga Nguyen, Bonnie W Leung, et al.
Pageof 4